Valvular & structural heart diseaseCohort study

Eligibility for Transcatheter Tricuspid Valve Interventions in Patients With Tricuspid Regurgitation

JACC Cardiovasc IntervPublished

  • Retrospective cohort study
  • consecutive patients

Authors' conclusion

Of 491 patients requiring TTVI, 32.0% had unfavorable anatomy for T-TEER, and 37.3% of patients with CCT images were eligible for TTVR. Despite the emergence of TTVR devices, 23.2% of patients with TR remained ineligible for both T-TEER and TTVR.

Study context

Population
Consecutive patients with tricuspid regurgitation (TR) considered for transcatheter tricuspid valve intervention in heart team conferences327 with cardiac computed tomographic (CCT) images
Participants
491 patients
Exposure
Favorable vs Feasible vs Unfavorable
  • Favorablen = 99
  • Feasiblen = 235
  • Unfavorablen = 157
Outcome
Prevalence of eligibility for T-TEER and TTVR devices

Main finding

As reported in the abstract

Anatomical feasibility for T-TEER
Ineligible for transcatheter tricuspid valve replacement (TTVR) (of 327 with CCT images)
205 (62.7%)
Ineligible for both tricuspid transcatheter edge-to-edge repair (T-TEER) and TTVR
23.2%

Observational data: associations, not effects.

Further findings

Reasons for unfavorable T-TEER anatomy

Large coaptation gap width
66.2%
Anteroposterior TR jet location
62.4%

Main reason for TTVR ineligibility

Tricuspid annuli larger than commercially available prosthesis sizes
65.4%

Original publication

Eligibility for Transcatheter Tricuspid Valve Interventions in Patients With Tricuspid Regurgitation. JACC Cardiovasc Interv. Published 9 December 2024. doi:10.1016/j.jcin.2024.09.019

Summarised from the published abstract; every number is checked against it